ROCM Rochester Medical Corporation
- 47.29 P/E
- 2.73 P/S
- 2.56 P/B
- 0.31 EPS
- 21.83% Cash ROIC
- 1.48 Cash Ratio
- 0 / 0% Dividend
- 77,621.00 Avg. Vol.
- 12.34M Shares
- 180.9M Market Cap.
Rochester Medical Corporation develops, manufactures, and markets urinary continence and urine drainage care products for the home care and acute/extended care markets in the United States, Europe, and internationally. Its extended care products include a line of male external catheters for managing male urinary incontinence and a line of intermittent catheters for managing male and female urinary...
NASDAQ - Apr 25, 2013
MarketWatch (press release) - Apr 25, 2013
SBWire (press release) - Apr 26, 2013
Globe and Mail - 14 hours ago
Canada's Valeant in talks to buy Bausch & Lomb for $9 bn - domain-B
University of Rochester Newsroom - May 21, 2013
Syracuse iSchool News - 18 hours ago
Bloomberg - May 24, 2013
R & D Magazine - May 24, 2013
Rochester Democrat and Chronicle - May 20, 2013
Syracuse.com - May 21, 2013